News
SGP
21.18
+12.60%
2.37
Weekly Report: what happened at SGP last week (0615-0619)?
Weekly Report · 6d ago
SPYGLASS PHARMA APPOINTS SHANNON TREVIÑO AS GENERAL COUNSEL
Reuters · 06/15 12:00
Weekly Report: what happened at SGP last week (0608-0612)?
Weekly Report · 06/15 10:46
Weekly Report: what happened at SGP last week (0601-0605)?
Weekly Report · 06/08 10:40
SpyGlass Pharma names Mike Pinder vice president, marketing
PUBT · 06/02 12:08
SPYGLASS PHARMA APPOINTS MIKE PINDER AS VICE PRESIDENT, MARKETING
Reuters · 06/02 12:00
Weekly Report: what happened at SGP last week (0525-0529)?
Weekly Report · 06/01 10:47
Analysts Offer Insights on NA Companies: SpyGlass Pharma (SGP) and Fiserv (FISV)
TipRanks · 05/29 11:40
Weekly Report: what happened at SGP last week (0518-0522)?
Weekly Report · 05/25 10:51
SpyGlass Pharma management joins Stifel virtual ophthalmology forum fireside chat
PUBT · 05/21 12:00
Jefferies Sticks to Its Buy Rating for SpyGlass Pharma (SGP)
TipRanks · 05/19 16:55
SpyGlass Pharma granted new CPT code for lens system
TipRanks · 05/18 13:24
SpyGlass Says AMA CPT Editorial Panel Approves New Add-On Category III CPT Code For Attachment, Insertion Of Intraocular Lens Prosthesis-Mounted Drug-Eluting Implant
Benzinga · 05/18 12:08
SPYGLASS PHARMA INC - BIM-IOL SYSTEM PHASE 3 TRIAL ENROLLMENT EXPECTED TO COMPLETE IN 2027
Reuters · 05/18 12:04
Weekly Report: what happened at SGP last week (0511-0515)?
Weekly Report · 05/18 10:50
SpyGlass Pharma (SGP) Receives a Buy from Stifel Nicolaus
TipRanks · 05/15 15:06
Spyglass Pharma publishes deck on long-acting intraocular drug delivery for glaucoma patients
PUBT · 05/15 13:10
SpyGlass Pharma, Inc. GAAP EPS of -$0.69
Seeking Alpha · 05/15 05:28
SpyGlass Pharma Q1 EPS $(0.69) Misses $(0.42) Estimate
Benzinga · 05/14 21:04
*SpyGlass Pharma 1Q Loss/Shr 69c >SGP
Dow Jones · 05/14 20:16
More
Webull provides a variety of real-time SGP stock news. You can receive the latest news about SpyGlass Pharma, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About SGP
SpyGlass Pharma Inc is a United States-based ophthalmic drug delivery company. The Company is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.